back to Australia directory
australia clinical guidance

Chlamydia (uncomplicated genital infection)

A detailed Australian summary of chlamydia (uncomplicated genital infection), with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Use nucleic-acid amplification testing from the appropriate anatomical sites based on sexual exposure, and test for other STIs according to risk. Treat confirmed uncomplicated infection with the current Australian STI guideline regimen after checking pregnancy, adherence and rectal involvement. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:Australian STI Guidelines

The Bottom Line

  • Use nucleic-acid amplification testing from the appropriate anatomical sites based on sexual exposure, and test for other STIs according to risk.
  • Treat confirmed uncomplicated infection with the current Australian STI guideline regimen after checking pregnancy, adherence and rectal involvement.
  • Rectal infection can be asymptomatic and requires exposure-based sampling because urine alone may miss it.
  • Provide partner notification support and advise abstinence for the guideline interval after treatment by the patient and relevant partners.
sources for this section:Australian STI Guidelines

Practical clinical workflow

1

Topic-specific assessment action

Use nucleic-acid amplification testing from the appropriate anatomical sites based on sexual exposure, and test for other STIs according to risk.
2

Topic-specific diagnostic action

Provide partner notification support and advise abstinence for the guideline interval after treatment by the patient and relevant partners.
3

Topic-specific management action

Arrange retesting for reinfection at the recommended interval and a test of cure only for specified circumstances such as pregnancy or selected regimens.
4

Topic-specific follow-through

Doxycycline product and pregnancy restrictions need current Australian guidance; do not substitute a convenience regimen without checking site efficacy.
sources for this section:Australian STI Guidelines

Safety boundaries and escalation

  • Pelvic pain, testicular pain, fever, pregnancy symptoms or disseminated features requires assessment for PID, epididymo-orchitis or another complication.
  • Use patient-delivered partner therapy only where legal and supported by the jurisdictional programme.
sources for this section:Australian STI Guidelines

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:Australian STI Guidelines

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Australian STI Guidelines

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Australasian Society for HIV, Viral Hepatitis and Sexual Health MedicineAustralian STI Management Guidelines for Use in Primary CareLiving web guideline checked 2026-08-20 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.